Related Experiment Videos
Reasons for patient drop-out from an intracavernous auto-injection programme for erectile dysfunction
D K Armstrong1, A G Convery, W W Dinsmore
1Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
British Journal of Urology
|July 1, 1994
Summary
Most patients stop intracavernous injections for erectile dysfunction due to non-treatment related issues. Understanding these factors can improve patient retention in erectile dysfunction programs.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Background:
- Intracavernous auto-injection therapy is an effective treatment for erectile dysfunction.
- Patient adherence and long-term treatment continuation are crucial for successful outcomes.
- High drop-out rates can limit the widespread adoption and effectiveness of this therapy.
Purpose of the Study:
- To investigate the primary reasons behind patient discontinuation of intracavernous auto-injection programs for erectile dysfunction.
- To identify factors influencing patient adherence and follow-up attendance in erectile dysfunction management.
Main Methods:
- A cohort of 47 patients who had previously benefited from intracavernous vasoactive agent treatment but missed follow-up appointments were studied.
- A self-administered questionnaire was used to collect data on reasons for withdrawal.
Main Results:
- A response rate of 64% (30 out of 47 patients) was achieved.
- The study outlines the specific reasons provided by patients for discontinuing intracavernous therapy.
Conclusions:
- The majority of patients who ceased intracavernous therapy did so for reasons independent of treatment-related complications or efficacy.
- Factors external to the treatment itself appear to be the main drivers of patient drop-out in erectile dysfunction injection programs.